| Assay ID | Title | Year | Journal | Article |
|---|
| AID248806 | Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D3 receptor | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID238948 | Inhibition of [125I]IABN binding to human Dopamine D3 receptor expressed in HEK 293 cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID65612 | Binding affinity towards rat Dopamine receptor D3 in Sf9 cells expressing in recombinant baculovirus (Bv) using [125I]IABN as radioligand | 2003 | Bioorganic & medicinal chemistry letters, Jul-07, Volume: 13, Issue:13
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. |
| AID238971 | Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID297341 | Binding affinity to human 5HT2C receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID297330 | Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID238970 | Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID237455 | cLogD was determined | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID297343 | Selectivity for human dopamine D3 receptor over human 5HT2A receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID21869 | Calculated partition coefficient (clogD) | 2003 | Bioorganic & medicinal chemistry letters, Jul-07, Volume: 13, Issue:13
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. |
| AID297337 | Agonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID297331 | Displacement of [125I]IABN from human dopamine D3 receptor expressed in HEK293 cells | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID248805 | Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID238642 | Binding affinity for human dopamine D2 receptor | 2005 | Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
| Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. |
| AID297333 | Selectivity for human dopamine D3 receptor over human dopamine D2 receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID65246 | Binding affinity towards rat Dopamine receptor D2 in Sf9 cells expressing in recombinant baculovirus (Bv) using [125I]IABN as radioligand | 2003 | Bioorganic & medicinal chemistry letters, Jul-07, Volume: 13, Issue:13
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. |
| AID243003 | Ratio of binding affinity at dopamine D2L over D3 receptors | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID297338 | Agonist activity at human dopamine D3 receptor expressed in HEK293 cells by mitogenesis assay | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID238749 | Binding affinity for human dopamine D3 receptor | 2005 | Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
| Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. |
| AID297340 | Binding affinity to human 5HT2A receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID64812 | Agonistic activity of quinpirole stimulation of mitogenesis in human Dopamine receptor D3 transfected CHO cells | 2003 | Bioorganic & medicinal chemistry letters, Jul-07, Volume: 13, Issue:13
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. |
| AID65295 | Stimulation of quinpirole stimulation of mitogenesis in human Dopamine receptor D3 transfected CHO cells | 2003 | Bioorganic & medicinal chemistry letters, Jul-07, Volume: 13, Issue:13
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. |
| AID63638 | Ratio of binding affinities of D2 receptor to D3 receptor | 2003 | Bioorganic & medicinal chemistry letters, Jul-07, Volume: 13, Issue:13
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. |
| AID238921 | Inhibition of [125I]IABN binding to rat Dopamine D2L receptor expressed in HEK 293 cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID297342 | Selectivity for human dopamine D3 receptor over human 5HT1A receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID238947 | Inhibition of [3H]YM-09151-2 binding to human Dopamine D3 receptor expressed in CHO cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID252264 | Intrinsic activity at Dopamine receptor D2 in CHO cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID297344 | Selectivity for human dopamine D3 receptor over human 5HT2C receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID243111 | Relative binding affinity for human dopamine D2 and D3 receptors | 2005 | Journal of medicinal chemistry, Feb-10, Volume: 48, Issue:3
| Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. |
| AID249049 | Compound tested for locomotor activity in male Swiss-Webster mice (n=8) | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID297332 | Displacement of [125I]IABN from human dopamine D4 receptor expressed in HEK293 cells | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID297339 | Binding affinity to human 5HT1A receptor | 2007 | Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
| Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. |
| AID238335 | Inhibition of rat Dopamine D3 receptor expressed in HEK 293 cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID252265 | Intrinsic activity at Dopamine receptor D3 in CHO cells | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| AID249398 | Dopamine receptor D2/D3 selectivity ratio from in vitro functional assays | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |